Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer

Clinical trial NCT03765190 · UNKNOWN

Trial details

NCT number: NCT03765190
Sponsor: Peking University First Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Proton Therapy Immunotherapy Neoplasm Metastasis

Start date: 2019-01-01
Primary completion: 2022-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.